Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

1(14.3%)

Phase 2

1(14.3%)

7Total

N/A(5)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06691698Not ApplicableRecruiting

Evaluation of CO-OP for Adolescents With Mild Intellectual Disability

Role: collaborator

NCT06247397Not ApplicableRecruiting

Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

Role: collaborator

NCT06275503Not ApplicableRecruiting

STROKESTOP III - Optimized Method for Atrial Fibrillation Screening

Role: collaborator

NCT05156307Unknown

Accuracy and Predictive Values for Colorectal Cancer of Quantitative FIT in Symptomatic Patients in Primary Care

Role: collaborator

NCT04426123Phase 2Unknown

Masseter Myofascial Pain Relief Following an Intra-muscular Injection With Botulinum Toxin Type A.

Role: collaborator

NCT03278457Unknown

Risk Stratification Using PET in HCM

Role: collaborator

NCT02976610Not ApplicableCompleted

Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department.

Role: collaborator

NCT01593319Phase 4Terminated

Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip

Role: lead

NCT01008488Not ApplicableCompleted

Antibiotic Therapy of Acute Uncomplicated Colonic Diverticulitis

Role: collaborator

All 9 trials loaded